| Literature DB >> 28800328 |
Annika Toots1,2, Håkan Littbrand1,2, Gustaf Boström2, Carl Hörnsten2, Henrik Holmberg3, Lillemor Lundin-Olsson1, Nina Lindelöf1,2, Peter Nordström2, Yngve Gustafson2, Erik Rosendahl1,2.
Abstract
BACKGROUND: Although physical exercise has been suggested to influence cognitive function, previous exercise studies show inconsistent results in people with dementia.Entities:
Keywords: Cognition; dementia; exercise; residential facilities
Mesh:
Year: 2017 PMID: 28800328 PMCID: PMC5611799 DOI: 10.3233/JAD-170014
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472
Fig.1Flow of participants through the study. ADLs, Activities of Daily Living; MMSE, Mini-Mental State Examination.
Baseline characteristics
| Characteristic | Total | Exercise | Control |
| Age | 85.1 (7.1) | 84.4 (6.2) | 85.9 (7.8) |
| Female, | 141 (75.8) | 70 (75.3) | 71 (76.3) |
| Dementia type, | |||
| Vascular dementia | 77 (41.4) | 36 (38.7) | 41 (44.1) |
| Alzheimer’s disease | 67 (36.0) | 34 (36.6) | 33 (35.5) |
| Other | 27 (14.5) | 15 (16.1) | 12 (12.9) |
| Mixed Alzheimer’s disease/Vascular dementia | 15 (8.1) | 8 (8.6) | 7 (7.5) |
| Diagnoses and medical conditions, | |||
| Depressive disorders | 107 (57.5) | 53 (57.0) | 54 (58.1) |
| Delirium previous week | 102 (54.8) | 48 (51.6) | 54 (58.1) |
| Previous Stroke | 57 (30.6) | 33 (35.5) | 24 (25.8) |
| Heart failure | 56 (30.1) | 24 (25.8) | 32 (34.4) |
| Previous hip fracture | 53 (28.5) | 28 (30.1) | 25 (26.9) |
| Angina pectoris | 49 (26.3) | 21 (22.6) | 28 (30.1) |
| Diabetes mellitus | 29 (15.6) | 18 (19.4) | 11 (11.8) |
| Prescription medication, | |||
| Analgesics | 112 (60.2) | 55 (59.1) | 57 (61.3) |
| Antidepressants | 102 (54.8) | 58 (62.4) | 44 (47.3) |
| Diuretics | 88 (47.3) | 41 (44.1) | 47 (50.5) |
| Vitamin D-Calcium supplement | 60 (32.3) | 32 (34.4) | 28 (30.1) |
| Cholinesterase inhibitor | 40 (21.5) | 25 (26.9) | 15 (16.1) |
| Benzodiazepines | 40 (21.5) | 19 (20.4) | 21 (22.6) |
| Neuroleptics | 31 (16.7) | 11 (11.8) | 20 (21.5) |
| Memantine | 12 (6.5) | 7 (7.5) | 5 (5.4) |
| Number of drugs, mean (SD) | 8.3 (3.8) | 8.4 (4.0) | 8.2 (3.7) |
| Assessments | |||
| Mobility Device, | 145 (78.0) | 76 (81.7) | 69 (74.2) |
| Mini Nutritional Assessment (0–30), | 21.1 (2.7) | 21.3 (2.8) | 20.9 (2.6) |
| Geriatric Depression Scale-15 (0–15), | 3.8 (3.2) | 4.0 (3.4) | 3.6 (2.9) |
| Neuropsychiatric Inventory (0–144)b | 14.8 (14.2) | 15.2 (15.8) | 14.4 (12.6) |
| Vision impairment, | 26 (14.0) | 10 (10.8) | 16 (17.2) |
| Hearing impairment, | 52 (28.0) | 20 (21.5) | 32 (34.4) |
| Self-reported health; good, very good, or excellent, | 119 (64.0) | 60 (64.5) | 59 (63.4) |
| | |||
| Barthel ADL Index (0–20)a | 10.9 (4.4) | 10.7 (4.5) | 11.0 (4.4) |
| Berg Balance Scale (0–56)a | 28.9 (14.5) | 28.6 (14.3) | 29.3 (14.7) |
| Outcome measures | |||
| Mini-Mental State Examination (0–30)a | 14.9 (3.5) | 15.4 (3.4) | 14.4 (3.5) |
| Alzheimer’s disease assessment scale – Cognitive | 31.6 (10.8) | 31.8 (11.4) | 31.3 (10.3) |
| section (0–70), | |||
| Verbal fluency, | 6.4 (3.8) | 6.8 (4.1) | 5.9 (3.5) |
Values are mean (SD) unless stated otherwise. Numbers reported after covariates indicate number of measurements available when values were missing. aHigher scores indicate better status. bLower scores indicate better status. cWhen at least 10 Geriatric Depression Scale (GDS-15) questions were answered, missing data were imputed using the mean score of questions answered. dUnable to read words printed in 5-mm capital letters, with or without glasses, at a normal reading distance. eUsing hearing aid and/or unable to hear a conversation held at usual speaking voice from a distance of 1 meter. SD, standard deviation.
Within- and between-group differences from baseline in the Mini-mental state examination (MMSE), the Verbal fluency test (VF), and the Alzheimer’s disease assessment scale –cognitive section (ADAS-Cog)
| Within-group differences | Between-group differences | ||||||
| Measure | Exercise, Mean m/s (SE) | Control, Mean m/s (SE) | Mean m/s (95% CI) | ICCa | |||
| MMSE | 0.11 | ||||||
| 4 months | 81 | –1.15 (0.41) | 85 | –0.93 (0.4) | –0.27 (–1.4 to 0.87) | 0.644 | |
| 7 months | 75 | –2.25 (0.42) | 76 | –1.11 (0.42) | –1.15 (–2.32 to 0.03) | 0.056 | |
| VF | 0.04 | ||||||
| 4 months | 80 | –0.74 (0.32) | 81 | –0.21 (0.32) | –0.53 (–1.42 to 0.35) | 0.241 | |
| 7 months | 74 | –0.89 (0.33) | 72 | –0.71(0.33) | –0.18 (–1.09 to 0.74) | 0.707 | |
| ADAS-Cog | 0.08 | ||||||
| 4 months | 84 | 1.51 (1.06) | 82 | 2.55 (1.07) | –1.04 (–4 to 1.92) | 0.491 | |
Values are from linear mixed-effects models adjusted for age, sex, and antidepressant use. aBased on proportion of variation explained by cluster. ICC, intracluster correlation coefficient; n, number of participants with complete data.
Fig.2Between-group differences from baseline in Mini-Mental State Examination (MMSE) and Verbal fluency (VF). Values are least square mean change from baseline, with 95% confidence intervals, from linear mixed-effects models adjusted for age, sex, and antidepressant use.